Terms: = Uterine cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
177 results:
1. Transcriptome analysis of an AKT inhibitor-resistant endometrial cancer cell line.
Onishi T; Takashima T; Shibahara K; Takagi S; Tanaka S; Mori M; Odashima H; Osawa Y; Hattori M
Pharmacol Rep; 2024 Apr; 76(2):379-389. PubMed ID: 38478219
[TBL] [Abstract] [Full Text] [Related]
2. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical markers Ki67 and p16 help predict prognosis in locally advanced cervical cancer.
Wu J; Wang R; Chen W; Wu Y; Xiao L
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
[TBL] [Abstract] [Full Text] [Related]
4. Autophagy-related risk signature based on CDNK2A to facilitate survival prediction of patients with endometrial cancer.
Yue C; Lin B; Sun X; Xu X; Zhou C; Fan J
J Gene Med; 2024 Jan; 26(1):e3648. PubMed ID: 38282156
[TBL] [Abstract] [Full Text] [Related]
5. Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2024 Jan; 103(3):e37001. PubMed ID: 38241535
[TBL] [Abstract] [Full Text] [Related]
6. Is HPV-negative cervical carcinoma a different type of cervical cancer?
Kulhan M; Bilgi A; Avci F; Ucar MG; Celik C; Kulhan NG
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9205-9212. PubMed ID: 37843334
[TBL] [Abstract] [Full Text] [Related]
7. The Identification of Gamma-Glutamyl Hydrolase in uterine Corpus Endometrial Carcinoma: a Predictive Model and Machine Learning.
Zhu C; Du Y; Huai Q; Fang N; Xu W; Yang J; Li X; Zhang Y; Zhang X; Dai H; Li X; Wang H; Dai Y
Reprod Sci; 2024 Feb; 31(2):532-549. PubMed ID: 37798609
[TBL] [Abstract] [Full Text] [Related]
8. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
[TBL] [Abstract] [Full Text] [Related]
9. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract] [Full Text] [Related]
10. The usefulness of p16 and COX-2 expression on the prediction of progression to endometrial cancer.
Kalkan HE; Akman L; Serin G; Terek MC; Zekioglu O; Ozsaran AA
Histol Histopathol; 2024 May; 39(5):565-571. PubMed ID: 37503793
[TBL] [Abstract] [Full Text] [Related]
11. Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal cancer prognosis.
Fujita Y; Fukuda Y; Sanuki F; Irei I; Monobe Y; Uno M; Akisada T; Shimoya K; Hara H; Moriya T
Head Neck Pathol; 2023 Sep; 17(3):658-672. PubMed ID: 37486532
[TBL] [Abstract] [Full Text] [Related]
12. High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma.
Hao J; Liu T; Xiu Y; Yuan H; Xu D
Front Immunol; 2023; 14():1208223. PubMed ID: 37388735
[TBL] [Abstract] [Full Text] [Related]
13. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Nigon E; Lefeuvre-Plesse C; Martinez A; Chauleur C; Lortholary A; Favier L; Bats AS; Guille A; AdélaÏde J; Finetti P; de Casteljac V; Provansal M; Mamessier E; Bertucci F; Ray-Coquard I; Sabatier R
J Transl Med; 2023 Jun; 21(1):408. PubMed ID: 37353806
[TBL] [Abstract] [Full Text] [Related]
14. [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
Zhang CN; Liu XY; Li Q; Song YZ; Liu B; Yin J; Yang JH; Zhong L; Sun L; Zhang X; Chen W
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):402-409. PubMed ID: 37188625
[No Abstract] [Full Text] [Related]
15. Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer.
Amin FAS; Un Naher Z; Ali PSS
J Cancer Res Clin Oncol; 2023 Aug; 149(10):8077-8086. PubMed ID: 37000261
[TBL] [Abstract] [Full Text] [Related]
16. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
17. Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.
Asami Y; Kobayashi Kato M; Hiranuma K; Matsuda M; Shimada Y; Ishikawa M; Koyama T; Komatsu M; Hamamoto R; Nagashima M; Terao Y; Itakura A; Kohno T; Sekizawa A; Matsumoto K; Kato T; Shiraishi K; Yoshida H
Br J Cancer; 2023 Apr; 128(8):1582-1591. PubMed ID: 36797358
[TBL] [Abstract] [Full Text] [Related]
18. Expression of fascin in association with p16 and Ki-67 in cervical lesions: immunohistochemical study.
Csizmár S; Výbohová D; Mešt'anová V; Krajňáková B; Kajo K; Kunertová L; Adamkov M
Pol J Pathol; 2022; 73(3):208-214. PubMed ID: 36734435
[TBL] [Abstract] [Full Text] [Related]
19. m
Fang F; Wang P; Huang H; Ye M; Liu X; Li Q
BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
[Next]
